Sugi Predict

Sugi Predict / Compounds / SCHEMBL1465490

SCHEMBL1465490

SCHEMBL1465490

CCOc1ccccc1C1(NC(=O)N2CCN(C3CCN(C)CC3)CC2)C(=O)N(S(=O)(=O)c2cccs2)c2ccc(Cl)cc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ MAPT P10636 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CCR1 P32246 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ MAPK7 Q13164 1/20 0.35
▸ AVPR1B P47901 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ MEN1 O00255 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1465296 0.92 AVPR1B (0.38) SMN1; SMN2MAPTGAATSHRALDH1A1
SCHEMBL16857939 0.91 SMN1; SMN2 (0.38) SMN1; SMN2MAPTGAATSHRCCR1
Hydrochloric Acid SCHEMBL1799722 0.90 AVPR1B (0.39) SMN1; SMN2MAPTALDH1A1MAPK1L3MBTL1
SCHEMBL1465380 0.90 BRD4 (0.36) SMN1; SMN2MAPTALDH1A1MAPK1L3MBTL1
SCHEMBL1796590 0.89 AVPR1B (0.43) GAAAVPR1B
SCHEMBL1795394 0.88 AVPR1B (0.43) BRD4MAPK7AVPR1B
Hydrochloric Acid SCHEMBL1466591 0.88 AVPR1B (0.39) MAPTMAPK1L3MBTL1BRD4MAPK7
SCHEMBL1797049 0.88 MAPT (0.36) SMN1; SMN2MAPTALDH1A1MAPK1L3MBTL1
SCHEMBL1799424 0.88 AVPR1B (0.43) ALDH1A1AVPR1BKMT2AMEN1
Hydrochloric Acid SCHEMBL1799628 0.88 MAPT (0.35) SMN1; SMN2MAPTGAAALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110077241-A1 HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM ABBOTT GMBH & CO. KG (DE) 2011-03-31 — — US disclosed
US-20110071156-A1 HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM ABBOTT GMBH & CO. KG (DE) 2011-03-24 — — US disclosed
US-7902379-B2 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them ABBOTT GMBH & CO. KG (DE) 2011-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071156-A1 HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM OXTR, AVPR2, AVPR1A SMN1; SMN2 3286/4885MAPT 3081/4885GAA 4553/4885
US-20110077241-A1 HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM OXTR, AVPR2, AVPR1A SMN1; SMN2 3286/4885MAPT 3081/4885GAA 4553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.